Cumberland Pharmaceuticals Inc.
CPIX
$2.28
$0.125.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.33M | -2.93M | -3.28M | -6.48M | -10.87M |
| Total Depreciation and Amortization | 5.74M | 5.82M | 5.92M | 6.04M | 5.62M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -196.90K | -905.90K | -1.04M | -1.47M | 2.01M |
| Change in Net Operating Assets | 4.62M | 5.14M | 3.81M | 1.29M | 1.77M |
| Cash from Operations | 6.83M | 7.12M | 5.42M | -612.20K | -1.48M |
| Capital Expenditure | -100.20K | -91.80K | -72.50K | -66.50K | -112.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.56M | -687.70K | -1.04M | 124.30K | 458.10K |
| Cash from Investing | -1.66M | -779.50K | -1.11M | 57.80K | 345.20K |
| Total Debt Issued | 5.50M | 16.49M | 27.49M | 38.49M | 40.69M |
| Total Debt Repaid | -16.35M | -27.34M | -38.33M | -36.00M | -37.52M |
| Issuance of Common Stock | 5.27M | 5.27M | 5.27M | -- | -- |
| Repurchase of Common Stock | -361.90K | -450.30K | -577.30K | -579.00K | -669.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.50M | -1.56M | -1.60M | -1.72M | -2.41M |
| Cash from Financing | -7.44M | -7.59M | -7.75M | 196.90K | 88.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.27M | -1.25M | -3.44M | -357.40K | -1.04M |